Alto Neuroscience Inc. (ANRO)
NYSE · Manufacturing · Pharmaceutical preparations
$26.49−$0.6900 (−2.54%) on the dayAs of the close; data may be delayed.
ANRO price, last 12 months
Key stats
- Previous close
- $27.18
- Open
- $27.36
- Day range
- $26.48 – $27.62
- 52-week range
- $3.77 – $37.48
- Volume
- 366.3K
- Avg volume (20 days)
- 563.2K
- Market cap
- $1.0B
Performance
1W−12.5%
1M−27.5%
3M−2.0%
6M+27.2%
YTD+48.8%
1Y+582.7%
vs S&P 500, 1Y+566.0 pts
Technicals and fundamentals
About Alto Neuroscience Inc.
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE
- Market cap
- $1.0B